Ret Proto-Oncogene anticorps (C-Term, Leu1027)

N° du produit ABIN2350377

Cet anticorps anti-Ret Proto-Oncogene est un anticorps Lapin Polyclonal détectant Ret Proto-Oncogene dans WB, ELISA et IHC. Adapté pour Humain.

Aperçu rapide pour Ret Proto-Oncogene anticorps (C-Term, Leu1027) (ABIN2350377)

Antigène: Ret Proto-Oncogene (RET)

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Ret Proto-Oncogene est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Détail du produit anti-Ret Proto-Oncogene anticorps

Épitope: AA 1012-1042, C-Term, Leu1027

Réactivité croisée: Humain

Réactivité croisée (Details): Calculated cross reactivity: Hu

Attributs du produit: RET, CT (L1027) (RET, CDHF12, CDHR16, PTC, RET51, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret, Soluble RET kinase fragment, Extracellular cell-membrane anchored RET cadherin 120kD fragment)

Purification: Purified by Ammonium Sulfate Precipitation.

Immunogène: KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 1012-1042 in the C-terminal region of Human RET UniProt Accession #P07949.

Isotype: IgG

Information d'application

Indications d'application: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur Ret Proto-Oncogene

Antigène: Ret Proto-Oncogene (RET)

Autre désignation: RET

UniProt: P07949

Pathways: Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation